Daniel Cua, Ph.D.,
Vice President, Pathway Area Leader, IL-23 at The Janssen Pharmaceutical Companies of Johnson & Johnson | Newark, Delaware, United States
Engage
candidates 10x faster
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 1.4M users from 76% of Fortune 500 companies
The most accurate data ever
CCPA Compliant
GDPR Compliant
150M
Personal Emails
200M
Work Emails
100M
Direct Dials
250M
Professional Profiles
40M
Company Profiles
Find anyone, anywhere
with ContactOut
today
Making remote or global hires?
Connecting
with key decision-makers? We can help.
- 40 emails / month
- 3 phone numbers / month
- Works on standard LinkedIn only
-
Work emails, personal emails,
mobile numbers
No credit card required
As Vice President and Pathway Area Leader for IL-23 at The Janssen Pharmaceutical Companies of Johnson & Johnson, Daniel plays a pivotal role in spearheading innovative therapeutic strategies within the Immunology Therapeutic Area. His leadership of a multi-disciplinary team encompasses Target Discovery, Compound Development, Translational Medicine, Clinical Development, and Commercial Strategy, fostering a collaborative environment that drives the discovery and development of novel IL-23 pathway therapies. Daniel's expertise in autoimmunity and drug discovery is complemented by his extensive background in molecular biology and protein chemistry, allowing him to navigate complex scientific challenges with precision.
Currently, Daniel is leading key projects focused on the development of cutting-edge therapies targeting the IL-23 pathway, which have shown promise in treating various autoimmune conditions. His contributions as a co-inventor on seven patents underscore his innovative approach to targeting IL-17 and IL-23, positioning him at the forefront of therapeutic advancements in the field. By leveraging his skills in assay development, in vitro studies, and animal models, Daniel ensures that the transition from bench to bedside is both efficient and effective.
Daniel's strategic vision not only enhances the scientific rigor of the projects under his leadership but also aligns with the broader goals of the Janssen organization. His ability to integrate clinical insights with commercial strategy ensures that the therapies developed are not only scientifically sound but also meet the needs of patients and healthcare providers alike. Through his unwavering commitment to advancing immunology, Daniel is shaping the future of treatment options for individuals affected by autoimmune diseases.
Vice President, Pathway Area Leader, IL-23 at The Janssen Pharmaceutical Companies of Johnson & Johnson in August 2019 to Present
Group Lead, Immunology and Immuno-oncology Discovery at Merck in October 2013 to July 2019
Senior Principal Scientist, Autoimmunity and Inflammation at Merck in November 2009 to October 2013
Senior Principal Scientist at Schering-Plough Biopharma in June 2007 to September 2009
Principal Scientist at Schering-Plough Biopharma in August 2004 to May 2007
Associate Principal Scientist at Schering-Plough Biopharma in January 2001 to July 2003
Research Fellow at DNAX Research Institute in July 1997 to December 2000
See more
See less
Autoimmunity
Inflammation
Drug Discovery
In Vivo
Biomarkers
Molecular Biology
Immunology
Lifesciences
Protein Chemistry
Cell
In Vitro
Assay Development
Antibodies
Life Sciences
Biotechnology
Cell Biology
Drug Development
Pharmaceutical Industry
Clinical Development
Oncology
Biopharmaceuticals
Animal Models
Monoclonal Antibodies
See more
See less
Discover more about The Janssen Pharmaceutical Companies of Johnson & JohnsonWhat is Daniel email address?
Email Daniel at [email protected]. This email is the most updated Daniel's email found in 2026.
How to contact Daniel?
To contact Daniel send an email to [email protected].
What company does Daniel Cua, Ph.D., work for?
Daniel Cua, Ph.D., works for The Janssen Pharmaceutical Companies of Johnson & Johnson
What is Daniel Cua, Ph.D.,'s role at The Janssen Pharmaceutical Companies of Johnson & Johnson?
Daniel Cua, Ph.D., is Vice President, Pathway Area Leader, IL-23
What is Daniel Cua, Ph.D.,'s Phone Number?
Daniel Cua, Ph.D.,'s phone (302) ***-*122
What industry does Daniel Cua, Ph.D., work in?
Daniel Cua, Ph.D., works in the Biotechnology industry.
Daniel Cua, Ph.D., Email Addresses
Daniel Cua, Ph.D., Phone Numbers
looking for?
Find personal and work emails for over 250M professionals.
People like Daniel Cua, Ph.D.,
Scientific Director, API Protein, BioTherapeutics and Supply at The Janssen Pharmaceutical Companies of Johnson & Johnson
Global Program Leader - Medical Affairs Operations at The Janssen Pharmaceutical Companies of Johnson & Johnson
Stealth NewCo at Atlas Venture
Chief Executive Officer and Director at Biological Dynamics
Sr. Director of Business Development at Culture Biosciences
President at HARVEST FOR THE HUNGRY INC
Founder & CTO at Meenta
Senior Advisor at New Horizons Dental Practice Management
Director Of Food And Beverage at Thompson San Antonio Riverwalk
Head of Finance at Pulse Films
Operations Manager at Lazy Dog Restaurant & Bar
Associate Professor at Columbia University in the City of New York
Senior Project Manager - Data Product Lead, Global Security at Starbucks
Lead Technology Specialist at VML
Director, Market Access Analytics, Real World Value & Evidence at The Janssen Pharmaceutical Companies of Johnson & Johnson
Associate Director, Sourcing & Alliance Managment at Janssen, Pharmaceutical Companies of Johnson and Johnson
Associate Scientific Director, Nonclinical Safety at The Janssen Pharmaceutical Companies of Johnson & Johnson
Head of Social and Digital at SID LEE
Branch Manager at Broadview Mortgage Corporation - Corporate
Design Research + Strategy Lead at Quartet Health
Director/Teacher/Founder at tc tutoring
Principal Designer at Chewy
Principal at Fontaine & Nicoloro Consultants, Inc.
Associate Manager, Agency Development at Twitter
Show more
Show less